Mineralocorticoid receptor antagonists for acute myocardial infarction: a systematic review and meta-analysis of randomised controlled trials
Song Peng Ang, Jia Ee Chia, Bruno Bezerra Lima, Jose Iglesias, Eunseuk Lee, Chayakrit Krittanawong, Mahboob Alam, Debabrata Mukherjee · 2025
Read Mineralocorticoid receptor antagonists for acute myocardial infarction: a systematic review and meta-analysis of randomised controlled trials by Song Peng Ang, Jia Ee Chia, Bruno Bezerra Lima, Jose Iglesias, Eunseuk Lee, Chayakrit Krittanawong, Mahboob Alam, Debabrata Mukherjee (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12716514.txt.
Description
Drugs that block the hormone aldosterone, called mineralocorticoid receptor antagonists, help some heart patients, but their value right after a heart attack is disputed. Song Peng Ang and co-authors pool the evidence from randomized trials, searching three databases for studies that compared these drugs with placebo or usual care in adults with acute heart attack. Fifteen trials with 18,471 patients qualified.
Across all trials, the drugs leaned toward benefit but no result cleared the bar of significance: total deaths, heart-related deaths, heart failure, repeat attacks, and rhythm problems all trended lower without proof. One split did stand out. In trials that followed patients for more than six months, deaths from heart causes fell modestly and significantly. The authors conclude the drugs should not be routine for every heart attack patient. Longer treatment, they suggest, may pay off for high-risk patients instead.
Catalog record
| CREATOR | Song Peng Ang, Jia Ee Chia, Bruno Bezerra Lima, Jose Iglesias, Eunseuk Lee, Chayakrit Krittanawong, Mahboob Alam, Debabrata Mukherjee |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |